NT_1170x120_1-11-18

Jonathan Gavras

Novo Nordisk set to release Ozempic

Novo Nordisk set to release Ozempic

PLAINSBORO, N.J. — Novo Nordisk this week gained Food and Drug Administration approval for Ozempic (semaglutide injection), a medication for type 2 diabetes. Also this week, Novo Nordisk and pharmacy benefit manager Prime Therapeutics said they signed a value-based contract for Victoza (liraglutide injection), another type 2 diabetes medication. A glucagon-like peptide (GLP-1) receptor agonist,

Troubling Rx trends: Drug lawsuit ads, lax opioid disposal

Troubling Rx trends: Drug lawsuit ads, lax opioid disposal

Some recently released research uncovered a couple of disconcerting trends concerning prescription drugs. Lawsuit ads targeting prescription drugs and medical devices have caused at least 61 serious medical events, including six deaths, according to a report from the U.S. Chamber Institute for Legal Reform (ILR). This marks an increase from previous reports, ILR said. Titled

Walgreens gets help with Rx disposal effort

DEERFIELD, Ill. — Four prominent players in the health care sector are coming together to help combat opioid abuse by increasing the availability of Walgreens medication disposal kiosks. The goal is to collect 300 tons of unwanted medications over the next two years through kiosks at about 1,500 Walgreens stores nationwide. Walgreens now has about

Walgreens Rx disposal kiosk program adds partners

Walgreens Rx disposal kiosk program adds partners

DEERFIELD, Ill. — AmerisourceBergen, the Blue Cross Blue Shield Association, Pfizer and Prime Therapeutics are helping Walgreens fight the national opioid epidemic by expanding the availability of safe medication disposal kiosks. The drug chain said Wednesday that the effort will bring the medication disposal units to an additional 900 Walgreens stores near military bases and